Lv4
680 积分 2024-05-05 加入
Targeting ECM-producing cells with CAR-T therapy alleviates fibrosis in chronic kidney disease
5个月前
已完结
Safety and Preliminary Efficacy of Mesenchymal Stromal Cell (ORBCEL-M) Therapy in Diabetic Kidney Disease: A Randomized Clinical Trial (NEPHSTROM)
5个月前
已完结
<i>Rilparencel</i> (Renal Autologous Cell Therapy-REACT<sup>®</sup>) for Chronic Kidney Disease and Type 1 and Type 2 Diabetes: Phase 2 Trial Design Evaluating Bilateral Kidney Dosing and Redosing Triggers
5个月前
已完结
Kidney Disease Following Hematopoietic Stem Cell Transplantation
5个月前
已完结
Nephrotoxicity in CAR-T Cell Therapy
5个月前
已完结
Role of Chimeric Antigen Receptor–Expressing Cell Therapy in Immune-Mediated Kidney Diseases: A Review
5个月前
已完结
Utilization of Hydrogels in Mesenchymal Stem Cell-Based Therapy for Kidney Diseases
5个月前
已完结
Hyporesponsiveness to erythropoiesis-stimulating agents and renal survival in non-dialysis CKD patients
6个月前
已关闭
Erythropoiesis-Stimulating Agent Responsiveness and Mortality in Hemodialysis Patients: Results from a Cohort Study From the Dialysis Registry in Japan
6个月前
已完结
A Prospective, Self-Controlled Pilot Study of the Efficacy of Roxadustat for Erythropoietin Hyporesponsiveness in Patients Requiring Chronic Ambulatory Peritoneal Dialysis
7个月前
已完结
皖公网安备34019202002308
